{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:32:29Z","timestamp":1770996749813,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1548,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.fertnstert.2017.11.023","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T04:54:36Z","timestamp":1520484876000},"page":"501-507.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ulipristal acetate decreases transforming growth factor \u03b23 serum and tumor tissue concentrations in patients with uterine fibroids"],"prefix":"10.1016","volume":"109","author":[{"given":"Micha\u0142","family":"Ciebiera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"W\u0142odarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Wrzosek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"S\u0142abuszewska-J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Nowicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Jakiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2017.11.023_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib3","doi-asserted-by":"crossref","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","article-title":"Uterine fibroids","volume":"2","author":"Stewart","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/jc.2010-1450","article-title":"Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-beta3","volume":"96","author":"Sinclair","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib5","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajog.2015.03.019","article-title":"The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013","volume":"213","author":"Soliman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","article-title":"Etiology, symptomatology and diagnosis of uterine myomas","volume":"87","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib8","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.fertnstert.2016.09.007","article-title":"Influence of vitamin D and transforming growth factor \u03b23 serum concentrations, obesity, and family history on the risk for uterine fibroids","volume":"106","author":"Ciebiera","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib9","first-page":"93","article-title":"Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study","volume":"5","author":"Sabry","year":"2013","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.fertnstert.2015.05.031","article-title":"Role of vitamin D in uterine fibroid biology","volume":"104","author":"Brakta","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib11","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.fertnstert.2016.09.048","article-title":"Hypovitaminosis D and high serum transforming growth factor beta-3: important biomarkers for uterine fibroids risk","volume":"106","author":"Halder","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib12","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib13","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/endo.141.10.7719","article-title":"In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine\/intracrine mechanism","volume":"141","author":"Sumitani","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2004-823027","article-title":"Aromatase and leiomyoma of the uterus","volume":"22","author":"Shozu","year":"2004","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1447-0756.2009.01099.x","article-title":"Cytogenetic aberrations and the development of uterine leiomyomata","volume":"36","author":"El-Gharib","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/molehr\/gat083","article-title":"Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues","volume":"20","author":"Holdsworth-Carson","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.fertnstert.2004.04.030","article-title":"Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium","volume":"82","author":"Leppert","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)03154-0","article-title":"Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata","volume":"78","author":"Sozen","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib21","first-page":"3222","article-title":"Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy","volume":"81","author":"Dou","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.05.044","article-title":"The role of progesterone signaling in the pathogenesis of uterine leiomyoma","volume":"358","author":"Kim","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl 5","key":"10.1016\/j.fertnstert.2017.11.023_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1289\/ehp.00108s5791","article-title":"Advances in uterine leiomyoma research: the progesterone hypothesis","volume":"108","author":"Rein","year":"2000","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2010.05.011","article-title":"Short-term change in growth of uterine leiomyoma: tumor growth spurts","volume":"95","author":"Baird","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.fertnstert.2014.06.041","article-title":"With the advent of selective progesterone receptor modulators what is the place of myoma surgery in current practice","volume":"102","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib28","first-page":"313","article-title":"The place of selective progesterone receptor modulators (SPRMs) in myoma therapy","volume":"68","author":"Donnez","year":"2016","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/molehr\/8.12.1071","article-title":"Effects of GnRH analogues, \u2018add-back\u2019 steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression","volume":"8","author":"Chegini","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib30","first-page":"913","article-title":"Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta","volume":"86","author":"Lee","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib31","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.fertnstert.2009.01.081","article-title":"Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta 3","volume":"93","author":"Joseph","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2119\/molmed.2014.00053","article-title":"Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy","volume":"21","author":"Borahay","year":"2015","journal-title":"Mol Med"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","article-title":"A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays","volume":"195","author":"Leppert","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor beta 3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09513590.2015.1106471","article-title":"Ulipristal acetate for uterine fibroids: a systematic review and meta-analysis","volume":"32","author":"Kalampokas","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib41","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.fertnstert.2013.02.017","article-title":"Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18\u201330 years old): a pilot study","volume":"99","author":"Marsh","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/152460900318489","article-title":"Early normal menstrual cycle pattern and the development of uterine leiomyomas","volume":"9","author":"Sato","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib43","doi-asserted-by":"crossref","first-page":"e36935","DOI":"10.1371\/journal.pone.0036935","article-title":"Role of stem cells in human uterine leiomyoma growth","volume":"7","author":"Ono","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.fertnstert.2012.04.044","article-title":"Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells","volume":"98","author":"Mas","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib45","doi-asserted-by":"crossref","first-page":"17053","DOI":"10.1073\/pnas.1313650110","article-title":"Paracrine activation of WNT\/\u03b2-catenin pathway in uterine leiomyoma stem cells promotes tumor growth","volume":"110","author":"Ono","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1095\/biolreprod.108.075648","article-title":"Constitutive activation of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice","volume":"81","author":"Tanwar","year":"2009","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib47","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","article-title":"Transforming growth factor-beta 3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation","volume":"73","author":"Arici","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib48","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2015.04.025","article-title":"In\u00a0vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment","volume":"104","author":"Courtoy","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib49","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/humrep\/det265","article-title":"Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells","volume":"28","author":"Halder","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib50","article-title":"Ulipristal acetate and extracellular matrix production in human leiomyomas in\u00a0vivo: a laboratory analysis of a randomized placebo controlled trial","volume":"1","author":"Cox","year":"2017","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/aje\/kww015","article-title":"Associations of the transforming growth factor \u03b2\/Smad pathway, body mass index, and physical activity with breast cancer outcomes: results from the Shanghai Breast Cancer Study","volume":"184","author":"Su","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/jcm6010005","article-title":"The TGF-\u03b2\/Smad4 signaling pathway in pancreatic carcinogenesis and its clinical significance","volume":"6","author":"Ahmed","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib53","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2010-2131","article-title":"Al Hendy A. 1,25 Dihydroxyvitamin D3 reduces TGF \u03b23 induced fibrosis-related gene expression in human uterine leiomyoma cells","volume":"96","author":"Halder","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0167-4838(99)00279-4","article-title":"Tissue inhibitors of metalloproteinases: evolution, structure and function","volume":"1477","author":"Brew","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib55","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib56","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/molehr\/3.11.1005","article-title":"Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotropin releasing hormone agonist induced tumour regression","volume":"3","author":"Dou","year":"1997","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/aje\/kwh016","article-title":"Reproductive factors, hormonal contraception and risk of uterine leiomyomata in African-American women: a prospective study","volume":"159","author":"Wise","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.11.023_bib59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/EDE.0b013e31828acca0","article-title":"Vitamin D and the risk of uterine fibroids","volume":"24","author":"Baird","year":"2013","journal-title":"Epidemiology"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217320770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217320770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T07:22:10Z","timestamp":1666509730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028217320770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0015028217320770"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.11.023","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ulipristal acetate decreases transforming growth factor \u03b23 serum and tumor tissue concentrations in patients with uterine fibroids","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}